Switch theme
Sign up to access all valuation multiples
American Well Corp is a telehealth company enabling digital delivery of care for its customers. Its platform, Amwell, digital care delivery solution that equips health systems, health plans, government, and innovator clients with the tools to enable new models of care for their patients and members enabling care delivery across the full healthcare continuum - from primary and urgent care in the home to high acuity specialty consults, such as telestroke and telepsychiatry, in the hospital. It provides both on-demand and scheduled consultations. Its Health Plan Programs include Virtual Primary Care, Musculoskeletal Care, Dermatology Care, and Chronic Care among others.
2006
877
LTM Revenue $255M
LTM EBITDA -$99.2M
-$109M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
American Well has a last 12-month revenue (LTM) of $255M and a last 12-month EBITDA of -$99.2M.
In the most recent fiscal year, American Well achieved revenue of $254M and an EBITDA of -$185M.
American Well expects next 12-month revenue of XXX and NTM EBITDA of XXX
See American Well valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $255M | XXX | $254M | XXX | XXX | XXX |
| Gross Profit | $115M | XXX | $99.0M | XXX | XXX | XXX |
| Gross Margin | 45% | XXX | 39% | XXX | XXX | XXX |
| EBITDA | -$99.2M | XXX | -$185M | XXX | XXX | XXX |
| EBITDA Margin | -39% | XXX | -73% | XXX | XXX | XXX |
| EBIT | -$173M | XXX | -$218M | XXX | XXX | XXX |
| EBIT Margin | -68% | XXX | -86% | XXX | XXX | XXX |
| Net Profit | -$165M | XXX | -$208M | XXX | XXX | XXX |
| Net Margin | -65% | XXX | -82% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, American Well's stock price is $7.
American Well has current market cap of $107M, and EV of -$109M.
See American Well trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| -$109M | $107M | XXX | XXX | XXX | XXX | $-10.88 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, American Well has market cap of $107M and EV of -$109M.
American Well's trades at -0.4x EV/Revenue multiple, and 0.6x EV/EBITDA.
Equity research analysts estimate American Well's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
American Well has a P/E ratio of -0.6x.
See valuation multiples for American Well and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $107M | XXX | $107M | XXX | XXX | XXX |
| EV (current) | -$109M | XXX | -$109M | XXX | XXX | XXX |
| EV/Revenue | -0.4x | XXX | -0.4x | XXX | XXX | XXX |
| EV/EBITDA | 1.1x | XXX | 0.6x | XXX | XXX | XXX |
| EV/EBIT | 0.6x | XXX | 0.5x | XXX | XXX | XXX |
| EV/Gross Profit | -0.9x | XXX | n/a | XXX | XXX | XXX |
| P/E | -0.6x | XXX | -0.5x | XXX | XXX | XXX |
| EV/FCF | 1.0x | XXX | 0.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialAmerican Well's last 12 month revenue growth is 3%
American Well's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.4M for the same period.
American Well's rule of 40 is -83% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
American Well's rule of X is -31% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for American Well and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 3% | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | -39% | XXX | -73% | XXX | XXX | XXX |
| EBITDA Growth | -62% | XXX | -53% | XXX | XXX | XXX |
| Rule of 40 | -83% | XXX | -69% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | -31% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.3M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.4M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 30% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 34% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 124% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Doctor Care Anywhere | XXX | XXX | XXX | XXX | XXX | XXX |
| UniDoc Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Ping An Healthcare | XXX | XXX | XXX | XXX | XXX | XXX |
| Kooth | XXX | XXX | XXX | XXX | XXX | XXX |
| Atrys Health | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
American Well acquired XXX companies to date.
Last acquisition by American Well was XXXXXXXX, XXXXX XXXXX XXXXXX . American Well acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was American Well founded? | American Well was founded in 2006. |
| Where is American Well headquartered? | American Well is headquartered in United States of America. |
| How many employees does American Well have? | As of today, American Well has 877 employees. |
| Who is the CEO of American Well? | American Well's CEO is Dr. Ido Schoenberg, M.D.. |
| Is American Well publicy listed? | Yes, American Well is a public company listed on NYS. |
| What is the stock symbol of American Well? | American Well trades under AMWL ticker. |
| When did American Well go public? | American Well went public in 2020. |
| Who are competitors of American Well? | Similar companies to American Well include e.g. Doctor Care Anywhere, UniDoc Health, Ping An Healthcare, Kooth. |
| What is the current market cap of American Well? | American Well's current market cap is $107M |
| What is the current revenue of American Well? | American Well's last 12 months revenue is $255M. |
| What is the current revenue growth of American Well? | American Well revenue growth (NTM/LTM) is 3%. |
| What is the current EV/Revenue multiple of American Well? | Current revenue multiple of American Well is -0.4x. |
| Is American Well profitable? | Yes, American Well is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of American Well? | American Well's last 12 months EBITDA is -$99.2M. |
| What is American Well's EBITDA margin? | American Well's last 12 months EBITDA margin is -39%. |
| What is the current EV/EBITDA multiple of American Well? | Current EBITDA multiple of American Well is 1.1x. |
| What is the current FCF of American Well? | American Well's last 12 months FCF is -$107M. |
| What is American Well's FCF margin? | American Well's last 12 months FCF margin is -42%. |
| What is the current EV/FCF multiple of American Well? | Current FCF multiple of American Well is 1.0x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
